ライフサイエンスコーパス: functional outcome

1 ptor-ligand interaction occurs can influence functional outcome.

2 tinuous electroencephalography features with functional outcome.

3 in reference to immunological parameters and functional outcome.

4 treatment, was not associated with improved functional outcome.

5 impairments in both functional capacity and functional outcome.

6 ne ganglion stimulation is likely to improve functional outcome.

7 y over standard medical therapy for improved functional outcome.

8 ty disorder, and it is the best predictor of functional outcome.

9 hermore, cTBS significantly improved general functional outcome.

10 charge from the ICU was used as a measure of functional outcome.

11 infarction, adversely affecting clinical and functional outcome.

12 8-24 h after acute ischaemic stroke improved functional outcome.

13 ct recovery and, associated with it, general functional outcome.

14 mpaired in psychotic disorders and linked to functional outcome.

15 in limiting hematoma expansion or improving functional outcome.

16 of pelvic fractures has been shown to affect functional outcome.

17 tment effect of endovascular thrombectomy on functional outcome.

18 luid balance with hospital complications and functional outcome.

19 ity Score (r = 0.49; p = 0.01), but not with functional outcome.

20 edicted reduced functional capacity, but not functional outcome.

21 in patients who might otherwise have a good functional outcome.

22 ic injury and predicted discharge neurologic/functional outcome.

23 DHC on long-term ischemic stroke injury and functional outcome.

24 of fragmented IP3R1 can result in a distinct functional outcome.

25 e cerebral disability) was considered a good functional outcome.

26 es of EAP, cognition, clinical symptoms, and functional outcome.

27 alteplase versus saline irrigation improved functional outcome.

28 among EAP, cognition, negative symptoms, and functional outcome.

29 ulation, the ischaemic penumbra and clinical functional outcome.

30 , which is considered a major determinant of functional outcome.

31 ss, and/or cerebral edema may predict better functional outcome.

32 hat are related to distress; impairment; and functional outcome.

33 efore and after surgery were compared as the functional outcome.

34 ion, of whom 36.2% were discharged with good functional outcome.

35 e of the microenvironment in determining its functional outcome.

36 cohorts, including PCOs, complications, and functional outcomes.

37 aptic transmission and significantly improve functional outcomes.

38 promote this repair are expected to improve functional outcomes.

39 plexus allotransplantation and analyzed its functional outcomes.

40 d intake leading to negative nutritional and functional outcomes.

41 suffer from high complication rates and poor functional outcomes.

42 ractions but lead to unpredictably different functional outcomes.

43 intervention and no difference was found for functional outcomes.

44 two PA2G4 isoforms translate into different functional outcomes.

45 eatly reduced patient morbidity and improved functional outcomes.

46 determine which care processes can maximize functional outcomes.

47 velop post-injury epilepsy tend to have poor functional outcomes.

48 cant deficiencies of T and NK cells and poor functional outcomes.

49 evice and assessed its early performance and functional outcomes.

50 ia impacts clinical or left ventricular (LV) functional outcomes.

51 dict beneficial clinical, neurocognitive and functional outcomes.

52 patients is safe, feasible, and may improve functional outcomes.

53 sening retinopathy with objectively measured functional outcomes.

54 and deep retinal plexuses, correlating with functional outcomes.

55 cteristics associated with better (or worse) functional outcomes.

56 atures, surgical details, and anatomical and functional outcomes.

57 ents, which act together to promote specific functional outcomes.

58 MHs > 400 mum, improving both anatomical and functional outcomes.

59 er research is needed to understand pain and functional outcomes.

60 innate and adaptive responses with distinct functional outcomes.

61 ect between successful revascularization and functional outcomes.

62 injury and their association with long-term functional outcomes.

63 caffeine therapy is associated with improved functional outcomes 11 years later.

64 ogical, and neurorehabilitation details with functional outcomes 18 months after heterologous bilater

65 se severity, hospital complications and poor functional outcome (3-mo modified Rankin Score >= 3) was

66 The primary outcome was a favourable functional outcome 90 days after randomisation, defined

67 e predictive value of plasma GPBB for 90-day functional outcome, 90-day survival and acute lesion vol

68 ated with a significant shift towards better functional outcome (adjusted common OR 1.38 [95% CI 1.05

69 .31; 95% CI, 1.14-1.51; p < 0.001), and poor functional outcome (adjusted odds ratio, 1.25; 95% CI, 1

70 nsfusion was not associated with the 3-month functional outcome (adjusted odds ratio, 1.570; 95% CI,

71 Risk ratio of good functional outcome after any type of surgery was 1.40 (9

72 of CT infarction location in determining the functional outcome after DHC.

73 hether (minimally invasive) surgery improves functional outcome after ICH and to determine the optima

74 ovides valid and improved prognostication of functional outcome after ICH.

75 The aim of this study was to assess the functional outcome after lumbopelvic fixation (LPF) usin

76 for sensitive and graduated prognosis of the functional outcome after MI without gadolinium-based con

77 rmia/ischemia ratio was associated with good functional outcome after out-of-hospital cardiac arrest

78 to target scar components to enable improved functional outcome after spinal cord injury.

79 Part of the variability in functional outcome after stroke has been attributed to g

80 s a strong and negative predictor of general functional outcome after stroke, and its therapy remains

81 al anti-VEGF demonstrated worse anatomic and functional outcomes after being LTFU compared with eyes

82 To assess the functional outcomes after combined iris and intraocular

83 is the first national cohort study comparing functional outcomes after H-RT and C-RT reported by pati

84 s not associated with haematoma expansion or functional outcomes after ICH, regardless of haematoma l

85 patients who ultimately achieved independent functional outcomes after prolonged post-CA coma to iden

86 Evidence suggests that functional outcomes after TBI can show improvement or de

87 nd significant improvements in mortality and functional outcome among statin users.

88 imulant medication is associated with better functional outcomes, an impact on underlying adolescent

89 artery ligation remains an issue related to functional outcome, anastomotic leak rate, and oncologic

90 al to 65 was a significant predictor of poor functional outcome and 6-month mortality.

91 l functions that are directly related to the functional outcome and contribute to the quality of life

92 features were independently associated with functional outcome and improved the area under the curve

93 ary outcomes were mRS shift towards a better functional outcome and independent outcome (mRS 0-2) at

94 on devices is associated with better 3-month functional outcome and lower mortality rates.

95 associated with a higher likelihood of good functional outcome and lower odds of hemicraniectomy com

96 volume, perihaematomal oedema (PHO) volume, functional outcome and mortality after ICH.

97 nition of such CNS complications may improve functional outcome and survival, and thus knowledge on M

98 geable penumbra volumes were associated with functional outcome and whether they interacted with the

99 istic regression models were used to compare functional outcomes and HRQOL across diagnostic stages a

100 We report population-wide functional outcomes and HRQOL in men with all stages of

101 o the insured, uninsured patients have worse functional outcomes and increased mortality.

102 ation of the protein from DNA with different functional outcomes and involving different protein stoi

103 study was to explore the association between functional outcomes and mismatch negativity (MMN) activi

104 icant correlations were detected between the functional outcomes and MMN amplitudes at frontal and fr

105 traditional inpatient outcomes to long-term functional outcomes and mortality of surgical intensive

106 To compare neurocognitive and endocrine functional outcomes and survival at 5 years in young pat

107 ter a JP or a SE for low rectal cancer, QOL, functional outcome, and complications are comparable bet

108 Plasma sST2 predicts DCI, functional outcome, and mortality after SAH, independent

109 ect of early nutritional support on Frailty, Functional Outcomes, and Recovery of malnourished medica

110 rygium surgery was associated with a similar functional outcome as that of Vicryl sutures in terms of

111 was associated with a durable improvement in functional outcomes as assessed by Rotarod and Morris Wa

112 ter stroke provided long-term improvement in functional outcome, as DHC-treated mice exhibited improv

113 The primary outcome was functional outcome assessed by ordinal analysis of the m

114 lic events before discharge, and the 3-month functional outcome (assessed by modified Rankin Scale).

115 The primary endpoint was functional outcome, assessed by the modified Rankin Scal

116 ificant benefit in survival with a favorable functional outcome at 1 year.

117 The functional outcome at 12 months was determined with the

118 neficial effect of endovascular treatment on functional outcome at 2 years in patients with acute isc

119 OAC-ICH, VKA-ICH and NOAC-ICH, mortality and functional outcome at 3 months between patients with ICH

120 Endovascular thrombectomy improved functional outcome at 3 months both in patients who had

121 sion and perfusion deficits, but had similar functional outcome at 3 months.

122 Overall, patients on DOAC might have better functional outcome at 3 months.

123 ht junction) gene were associated with worse functional outcome at 3-month after stroke.

124 Functional outcome at 6 months was classified as good (C

125 safety, such as bleeding or infections, and functional outcome at 90 and 180 days.

126 tart of EVT time was associated with a worse functional outcome at 90 days (mRS = 0-2, adjusted odds

127 mary outcome was non-inferiority of clinical functional outcome at 90 days as measured by the percent

128 rst pass thrombectomy conferred non-inferior functional outcome at 90 days compared with stent retrie

129 ch, intravenous alteplase resulted in better functional outcome at 90 days than placebo or standard c

130 ult in a significant difference in favorable functional outcome at 90 days.

131 and the modified Rankin Scale (mRS) assessed functional outcome at 90 days.

132 Primary outcome was good functional outcome at follow-up; secondary outcomes were

133 ariants in PATJ gene associated with 3-month functional outcome at genome-wide significance level.

134 Clinical, echocardiographic, and functional outcomes at 1 year were evaluated.

135 ional bracing, did not significantly improve functional outcomes at 12 months.

136 cerebral oximetry index was associated with functional outcomes at 3 months (p = 0.019) and 6 months

137 by the time of hospital discharge and better functional outcomes at 3 months.

138 nction with standard care resulted in better functional outcomes at 90 days than standard care alone.

139 , 0.72 [95% CI, 0.54-0.98]), or to have good functional outcomes at discharge (modified Rankin Scale,

140 with alteplase did not substantially improve functional outcomes at the mRS 3 cutoff compared with ir

141 aling cascade that culminates in many of the functional outcomes attributed to 20-HETE in vitro and i

142 rvival and death of newly born neurons, with functional outcomes being dependent on both timing and c

143 While there was no difference in functional outcomes between both HMPO2 groups, there wer

144 e no significant differences in any of the 4 functional outcomes between the 0.40 mg/kg and 0.25 mg/k

145 hese difficulties are strongly predictive of functional outcomes, but there is a paucity of effective

146 tically augmenting efferocytosis may improve functional outcomes by both reducing tissue injury and p

147 engineering of this hotspot induces opposing functional outcomes by Stg and CNIH3.

148 Small studies have suggested acceptable functional outcomes can be achieved after pelvic exenter

149 ower dose, elicited a comparable or superior functional outcome compared with combined AZD-1208 + BEZ

150 Data on posttransplant survival and functional outcomes continue to be collected to further

151 ut-of-hospital cardiac arrests in Denmark to functional outcome data and reported the 1-year risks of

152 Six-month mortality and functional outcomes defined as modified Rankin scale (>=

153 The primary efficacy outcome was good functional outcome, defined as a modified Rankin Scale s

154 In addition, functional outcome, defined as changes in New York Heart

155 Primary outcome was good functional outcome, defined as the proportion of patient

156 A net benefit was observed for all functional outcomes despite an increased risk of symptom

157 Patients were grouped by functional outcome, determined by the modified Rankin Sc

158 able, regression models to predict long-term functional outcome (dichotomizations of the Glasgow Outc

159 ypes are highly comparable between siblings, functional outcomes differ substantially.

160 red FLAgs will enable precise delineation of functional outcomes directed by distinct receptor combin

161 r brain developmental trajectories predicted functional outcomes during late adolescence.

162 all improvements in some quality-of-life and functional outcomes (eg, less than 3 points on the 0 to

163 Overall, EAP had a fully mediated effect on functional outcome, engaging general rather than modalit

164 treatments demonstrated to improve long term functional outcomes following traumatic brain injury(TBI

165 Early mobilization after injury improves functional outcomes for patients, although when and how

166 of coma was significantly different between functional outcome groups at hospital discharge (p = 0.0

167 Secondary outcome measures were functional outcome, health-related quality of life, and

168 Functional outcome, however, did not differ among patien

169 5% CI = 0.17-0.45, p < 0.0001) and favorable functional outcome (HR = 4.08, 95% CI = 2.48-6.72, p < 0

170 ce of association of HP CNV or rs200999 with functional outcome, ICH volume or PHO volume.

171 The effect of homeostatic plasticity on functional outcomes identify it as a promising therapeut

172 n between the hypothermia/ischemia ratio and functional outcome in a secondary analysis of data from

173 We assessed functional outcome in ischaemic stroke patients with lar

174 Phagocytosis is measured as a functional outcome in many research fields, but accurate

175 during the chronic phase of stroke improves functional outcome in mice with no synergistic effects o

176 We assessed case fatality and functional outcome in patients treated conservatively or

177 ower high-frequency ultrasound could improve functional outcome in patients treated with alteplase af

178 icantly higher odds of achieving a favorable functional outcome in patients who were treated in a str

179 of body mass index (BMI) with mortality and functional outcome in patients with acute ischemic strok

180 ng clot size to 15 mL or less, would improve functional outcome in patients with intracerebral haemor

181 of the factors most strongly associated with functional outcome in schizophrenia, current treatment s

182 s only proven beneficial to histological and functional outcome in studies in which the rate of subcl

183 balance with hospital complications and poor functional outcome in subarachnoid hemorrhage patients.

184 and of impaired reading ability to impaired functional outcome in SZ.

185 clinical markers of injury severity but not functional outcome in this prospective cohort of patient

186 ings demonstrate that tPA improves long-term functional outcomes in a clinically relevant stroke mode

187 led to nearly equivalent graft survival and functional outcomes in HS pediatric patients as nonsensi

188 rent study was to determine patient-reported functional outcomes in men with prostate cancer (PCa) un

189 romising candidate as an evaluation tool for functional outcomes in mood disorders.

190 for cellular organization and specificity of functional outcomes in neurons.

191 ments, with additional guidelines for visual functional outcomes in patients with optic pathway tumou

192 ecovery therapy might be useful in improving functional outcomes in people with first-episode psychos

193 Comparison of their functional outcomes in prospective, randomized, multi-ce

194 ng memory (WM) deficits predict clinical and functional outcomes in schizophrenia but are poorly unde

195 cognitive function to predicting social and functional outcomes in schizophrenia, the authors carrie

196 ment Scale improvement >= 1 grade point) and functional outcomes in subjects who developed adverse ev

197 would be superior to alteplase in improving functional outcomes in the group of patients with target

198 h-1 treatment improved both histological and functional outcomes in the murine lung transplant model.

199 This study sought to assess clinical and functional outcomes in women with PPCM complicated by pr

200 ations and demonstrated a positive impact on functional outcomes, including a 34% reduction in anemia

201 r and to assess their impact on anatomic and functional outcomes, including outer retinal integrity.

202 ise relationship between these variables and functional outcome is unknown.

203 h acute ischemic stroke has an effect on the functional outcome is unknown.

204 associated with a higher likelihood of good functional outcome, lower odds of symptomatic intracrani

205 sordered breathing was associated with worse functional outcome (mean difference in activities of dai

206 s a measure of changing DA function may be a functional outcome measure in AMD clinical studies.

207 Functional outcomes measured by the absolute value and t

208 from IVT administration to start of EVT with functional outcome (measured with the modified Rankin Sc

209 ers that explained observed variation, using functional outcome measures as proxies for severity.

210 trials, which to date have relied solely on functional outcome measures for patient enrollment, stra

211 system significantly affects anatomical and functional outcome measures in a preclinical model of tr

212 e model of RLN injury provides several novel functional outcome measures to increase the translationa

213 disease (STGD) and correlate these data with functional outcome measures.

214 excellent results, as measured by objective functional outcome measures.

215 e in TGCT with improved patient symptoms and functional outcomes; mixed or cholestatic hepatotoxicity

216 ssociated with: (1) mortality, (2) favorable functional outcome (modified Rankin Scale = 0-3), and (3

217 Secondary outcomes showed differences in functional outcome (modified Rankin Scale=4-6: IHC: 29/3

218 demonstrated a decreased likelihood of good functional outcomes (modified Rankin score 0 to 2) when

219 (weighted) = 1.17 [95% CI = 0.73-1.88]), and functional outcome (mRS >= 3/ordinal mRS: OR(unadjusted)

220 nce in activities of daily living, excellent functional outcome (mRS 0-1), and mortality.

221 ith aHG had lower rates of 3-month favorable functional outcome (mRS scores 0-1, 34.1% vs. 39.3%, P <

222 associated with increased survival with good functional outcome (odds ratio, 2.01; 95% CI, 1.82-2.23)

223 We examine the functional outcome of 39 variants associated with System

224 mechanistic role for PTEN in determining the functional outcome of combined pathway blockade.

225 emia may delay motor recovery and impact the functional outcome of Guillain-Barre syndrome.

226 procrustes metric carries information on the functional outcome of injuries in the model.

227 compare prospectively the complications and functional outcome of patients undergoing a J-Pouch (JP)

228 asis for further studies to determine if the functional outcome of patients with stroke can be greatl

229 ss this challenge, we determine the temporal functional outcome of RAF1 during mouse neural progenito

230 This analysis of combined morphologic and functional outcomes of anti-VEGF therapy, the largest co

231 criptome data valuable for the prediction of functional outcomes of immune responses.

232 difficult to investigate the reasons of poor functional outcomes of microsurgical repairs in humans,

233 eration is a dynamic process synergizing the functional outcomes of multiple signaling circuits.

234 The primary outcome was change in Functional Outcomes of Sleep Questionnaire (FOSQ) score

235 fe (48% and 58%, respectively) as well as in functional outcomes of strength (56% of patients) and ra

236 To compare the anatomical and functional outcomes of the inverted internal limiting me

237 The functional outcomes of the neocorpus can be addressed by

238 of an ANKRD protein with its target and the functional outcomes of this interaction.

239 is predicted following many WGD events, the functional outcomes of WGD need not appear 'explosively'

240 definition), 3-month mortality, and 3-month functional outcome on the modified Rankin Scale (mRS) us

241 ging, lack of a reliable and easy-to-measure functional outcome or external standard, the confounding

242 refractory status epilepticus did not impact functional outcome or mortality at last follow-up.

243 None of the included studies examined functional outcome or quality of life measures, and card

244 illness does not improve quality of life or functional outcomes or increase the number of survivors

245 s superior neurocognitive and neuroendocrine functional outcomes over 5 years without compromising su

246 FLAIR-HAs were not associated with functional outcome overall (pooled risk ratio 0.87, 95%

247 FLAIR-HAs were not associated with functional outcome overall but were associated with outc

248 year was independently associated with poor functional outcome (P = 0.04), poor cognitive outcome (P

249 onitoring of macular diseases and serve as a functional outcome parameter.

250 patients was associated with better 3-month functional outcome (pooled OR, 1.35; 99% CI 1.04 to 1.76

251 Behavioral assays tested for functional outcomes, postmortem analyses assessed neurop

252 Outcomes were unfavourable functional outcome (primary, modified Rankin scale score

253 Validation of long-term functional outcome prognostication by the max-ICH Score

254 ion with, and do not consider observer-based functional outcomes related to distress.

255 .49, 95% CI 0.36 to 0.67; n=89 976) and poor functional outcome (RR 0.71, 95% CI 0.67 to 0.75; n=9113

256 .68, 95% CI 0.50 to 0.92; n=74 648) and poor functional outcome (RR 0.83, 95% CI 0.76 to 0.91; n=34 7

257 The primary outcome was favourable functional outcome (score of 0-1 on the modified Rankin

258 tors NFkappaB and AP-1 and promote different functional outcomes, such as inflammation, apoptosis, an

259 substantially higher likelihood of favorable functional outcome than those who receive standard care.

260 ToM), in schizophrenia more strongly predict functional outcomes than psychotic symptoms or nonsocial

261 usness by ICU discharge had better long-term functional outcomes than those predicted to remain uncon

262 specific activation of Smad3 has contrasting functional outcomes that may involve activation of an in

263 successful ET has high efficacy in improving functional outcomes, the decision to abort a long proced

264 Despite variable functional outcomes, third and fourth kidney transplant

265 AVR for PPM, hemodynamics, and clinical, and functional outcomes through 1-year follow-up within the

266 H) score and to compare its association with functional outcome to that of the original PICH score.

267 t to create a mouse model with translational functional outcomes to further investigate RLN regenerat

268 h aspiration as first pass have non-inferior functional outcomes to those treated with a stent retrie

269 questionnaire-8), PTSD (8Q-PCL-5), pain, and functional outcomes (trauma quality of life instrument,

270 tal enrichment in the chronic phase improves functional outcome up to 2 months post-stroke.

271 ant positions that manifests a wide range of functional outcomes upon substitution: "rheostat" positi

272 which contained validated measures to assess functional outcomes (urinary incontinence, urinary irrit

273 lly significant improvements in clinical and functional outcomes versus continuing methotrexate in th

274 t a model in which EAP deficits lead to poor functional outcome via impaired cognition and increased

275 st-myocardial infarction (MI) structural and functional outcomes via restored S1PR1 signaling, and so

276 ssociated with lower likelihood of favorable functional outcome (volume <=12 cm3, 30.6% vs 62.3% [P =

277 adjusted odds ratio for shift toward better functional outcome was 1.0 (95% confidence interval [CI]

278 y was 30% (95% CI 25% to 30%) and favourable functional outcome was 45% (95% CI 40% to 50%) and after

279 General functional outcome was assessed by means of the Function

280 Functional outcome was assessed by modified Rankin score

281 Three-month functional outcome was assessed.

282 Favourable functional outcome was defined as a modified Rankin Scal

283 Functional outcome was measured by the modified Rankin S

284 Functional outcome was measured by the Role Functioning

285 Functional outcome was not associated with the number of

286 Functional outcome was recorded using 3-month modified R

287 The indirect effect of EAP on functional outcome was significant as well (beta = 0.14,

288 The functional outcome was significantly correlated with lef

289 cycles per degree, cpd) with structural and functional outcomes was explored with correlation and re

290 Features associated with functional outcome were assessed from the ICU subgroup.M

291 cTBS responders, in whom neglect and general functional outcome were significantly improved, the corp

292 Functional outcomes were assessed by means of Western bl

293 Associations between various anatomic and functional outcomes were assessed.

294 Even though mostly favorable functional outcomes were reported throughout the literat

295 The functional outcomes were significantly worse in the ND a

296 tischemic ROS formation, infarct volume, and functional outcomes were worsened in NOX5-KI mice.

297 imental stroke, reduced EphA4 levels improve functional outcome with similar beneficial effects upon

298 Collectively, these studies correlate functional outcomes with a physical basis for signaling

299 with acute ischemic stroke have shown better functional outcomes with endovascular treatment than wit

300 Rankin scale at 2 years; this scale measures functional outcome, with scores ranging from 0 (no sympt